CL King Initiates Coverage On Axonics with Buy Rating, Announces Price Target of $75
Portfolio Pulse from richadhand@benzinga.com
CL King analyst Kristen Stewart initiates coverage on Axonics (NASDAQ:AXNX) with a Buy rating and announces a price target of $75.
May 23, 2023 | 11:01 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Axonics receives a Buy rating from CL King analyst Kristen Stewart, with a price target of $75.
The Buy rating and price target announcement by CL King analyst Kristen Stewart is a positive signal for Axonics. This could lead to increased investor interest and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100